Compare AHL & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHL | PBH |
|---|---|---|
| Founded | 2002 | 1996 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.9B |
| IPO Year | 2025 | 2005 |
| Metric | AHL | PBH |
|---|---|---|
| Price | $37.33 | $66.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $39.44 | ★ $85.40 |
| AVG Volume (30 Days) | 225.9K | ★ 399.7K |
| Earning Date | 02-27-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.46 | N/A |
| EPS | ★ 6.60 | 3.79 |
| Revenue | ★ $3,191,700,000.00 | $1,103,606,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.63 | $2.24 |
| P/E Ratio | ★ $5.65 | $17.29 |
| Revenue Growth | ★ 5.65 | N/A |
| 52 Week Low | $27.05 | $57.25 |
| 52 Week High | $37.40 | $90.04 |
| Indicator | AHL | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 64.90 | 52.57 |
| Support Level | $37.28 | $63.69 |
| Resistance Level | $37.37 | $68.62 |
| Average True Range (ATR) | 0.08 | 2.10 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 68.42 | 39.98 |
Aspen Insurance Holdings Ltd is a Bermudian insurance and reinsurance company. Its principal business is marketing and underwriting specialty insurance and reinsurance regularly. It comprises underwriting operations, which include risk-bearing insurance and reinsurance operations; Investing activities, which support underwriting operations; and ACM operations, which earn underwriting, management, and performance fees. It has two segments: Aspen Insurance and Aspen Reinsurance. Aspen Insurance consists of property and casualty insurance, marine, aviation, and energy insurance, and financial and professional lines insurance. Aspen Reinsurance comprises property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.